Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1687
https://www.valueinhealthjournal.com/article/S1098-3015(14)03617-1/fulltext
Title :
Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03617-1&doi=10.1016/j.jval.2014.08.1687
First page :
A531
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1161